Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
P. James, N. Rigby, R. Leach, I.O.T. Force.
The obesity epidemic metabolic syndrome and future prevention strategies.
Eur J Cardiovasc Prev Rehabil, 11 (2004), pp. 3-8
[3.]
F. Picard, M. Kurtev, N. Chung, A. Topark-Ngarm, T. Senawong, R. Machado de Oliveira, et al.
Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma.
Nature, 429 (2004), pp. 771-776
[4.]
L. Bai, W. Pang, Y. Yang, G. Yang.
Modulation of Sirt1 by resveratrol and nicotinamide alters proliferation and differentiation of pig preadipocytes.
Mol Cell Biochem, 307 (2008), pp. 129-140
[5.]
P. Fischer-Posovsky, V. Kakulus, D. Tews, T. Unterkircher, K.M. Debatin, S. Fulda, et al.
Resveratrol regulates human adipocyte number and function in a Sirt1-dependent manner.
Am J Clin Nutr, 92 (2010), pp. 5-15
[6.]
S. Rayalam, M. Della-Fera, J. Yang, H.J. Park, S. Ambati, C.A. Baile.
Resveratrol potentiates genistein's antiadipogenic and proapoptotic effects in 3T3-L1 adipocytes.
J Nutr, 137 (2007), pp. 2668-2673
[7.]
M. Lagouge, C. Argmann, Z. Gerhart-Hines, H. Meziane, C. Lerin, F. Daussin, et al.
Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha.
Cell, 27 (2006), pp. 1109-1122
[8.]
J. Baur, K. Pearson, N. Price, H. Jamieson, C. Lerin, A. Kalra, et al.
Resveratrol improves health and survival of mice on a high-calorie diet.
Nature, 444 (2006), pp. 337-342
[9.]
J. Ahn, I. Cho, S. Kim, D. Kwon, T. Ha.
Dietary resveratrol alters lipid metabolism-related gene expression of mice on an atherogenic diet.
J Hepatol, 49 (2008), pp. 1019-1028
[10.]
L. Rivera, R. Morón, A. Zarzuelo, M. Galisteo.
Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats.
Biochem Pharmacol, 77 (2009), pp. 1053-1063
[11.]
J. Shang, L.I. Chen, F.X. Xiao, H. Sun, H.C. Ding, H. Xiao.
Resveratrol improves non-alcoholic fatty liver disease nyactivating AMPactivated protein kinase.
Acta Pharmacol Sin, 29 (2008), pp. 698-706
[12.]
Y.T. Wong, J. Gruber, A.M. Jenner, M.P. Ng, R. Ruan, F.E. Tay.
Elevation of oxidative-damage biomarkers during aging in F2 hybrid mice: Protection by chronic oral intake of resveratrol.
Free Radic Biol Med, 46 (2009), pp. 799-809
[13.]
Lasa A, Schweiger M, Kotzbeck P, Churruca I, Simón R, Zechner R, et al. J Nutr Biochem. 2011.(in press)
[14.]
M.T. Macraulla, G. Alberdi, S. Gómez-Zorita, I. Tueros, C. Bald, V.M. Rodríguez, et al.
J Physiol Biochem, 65 (2009), pp. 369-376
[15.]
Alberdi G, Rodríguez VM, Miranda J, Macarulla MT, Arias N, Andrés-Lacueva C, et al. Nutr Metab. 2011.(en prensa)
[16.]
Gómez-Zorita S, Fernández-Quintela A, Macarulla MT, Aguirre L, Hijona E, Bujanda L, et al. Resveratrol attenuates steatosis in obese Zucker rats by decreasing fatty acid availability and reducing oxidative stress. Br J Nutr. 2011.(in press)
[17.]
C. De Santi, A. Pietrabissa, F. Mosca, G.M. Pacifici.
Glucuronidation of resveratrol, a natural product present in grape and wine, in the human liver.
Xenobiotica, 30 (2000), pp. 1047-1054
[18.]
M. Azorín-Ortuño, M.J. Yañéz-Gascón, F.J. Pallaré s, F. Vallejo, M. Larrosa, M.T. García-Conesa, et al.
Pharmacokinetic study of trans-resveratrol in adult pigs.
J Agric Food Chem, 58 (2010), pp. 11165-11171
Copyright © 2011. Asociación Española de Dietistas-Nutricionistas